ClinicalTrials.gg

Genrix (Shanghai) Biopharmaceutical Co., Ltd. clinical trials

A subsidiary of Chongqing Genrix Biopharmaceutical Co., Ltd

The registry lists 28 studies whose lead sponsor is Genrix (Shanghai) Biopharmaceutical Co., Ltd.. 17 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 10, 2026.

What it is testing

The drugs Genrix (Shanghai) Biopharmaceutical Co., Ltd.’s studies test, most open studies first — 5 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

5 of Genrix (Shanghai) Biopharmaceutical Co., Ltd.’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. 2M
  8. 1J
  9. 2J
  10. A
  11. S
  12. O
  13. N

Add all 5 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 17, 2026.

All 28 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1761%Not yet recruiting 9 · Recruiting 8
  • Under way, not recruiting414%
  • Completed725%

Phase

  • Phase 214
  • Phase 112
  • Phase 38

Where

Over the years

  1. 20
  2. 21
  3. 22
  4. 23
  5. 624
  6. 25
  7. 526

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Genrix (Shanghai) Biopharmaceutical Co., Ltd.28 studies

Something wrong with this grouping? Tell us on the Chongqing Genrix Biopharmaceutical Co., Ltd page.

Studies

Recruiting first, then most recently updated. Showing 28 of 28. All Chongqing Genrix Biopharmaceutical Co., Ltd studies →